CRP and metabolic syndrome: We hypothesized that administration of vitamin C (1000 mg/d) with other selected micronutrients would decrease systemic inflammation (i.e., CRP concentrations) in people with metabolic syndrome, thus providing a window of opportunity to potentially reverse or halt progression of the condition to the more severe cardiometabolic diseases.